
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+10
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug development journey with well characterized in vitro and in vivo disease models in addition to general drug development services, providing valuable insights into the mode of action, pharmacokinetics, safety, and efficacy of investigational compounds. Our services are designed with personalized tailoring in mind, supported by innovative technical capabilities and are executed in close collaboration with our partners. With a focus on nephrology, immuno-oncology, neurology...
Organoids,patient derived xenografts,oncology,parkinson's disease,polycystic kidney disease,in-vivo imaging,digital pathology,facility management,gemm generation,in-vivo pharmacology,transgenic services,cryopreservation,sanitation,rederivation,and drug development
Innoser operates in the Biotechnology research industry.
Innoser's revenue is 11m - 100m
Innoser has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.